HeartSciences Inc. (HSCS) News
Follow HeartSciences Inc. (HSCS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiograph
HeartSciences Inc. (NASDAQ: HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of arti
LIVE | Oct 06, 2026, 02:50 PM UTC
M
Fortitude Mining Secures Zcash Mining Equipment Supply, $100M Purchase Commitment
Fortitude Mining, LLC has entered into a letter of intent with BITMAIN Technologies Delaware Limited for a priority supply allocation of next-generation Zcash mining equipment. Fortitude also announced a $100 million non
CRYPTO | Oct 05, 2026, 10:10 PM UTC
L
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
Fortitude Mining Holdings, Inc. (“Fortitude” or the “Company”), a vertically-integrated digital asset mining platform anchored in Zcash, today announced the appointment of Kimberly Pittman as Chief Legal Officer, effecti
NEWS | Sep 29, 2026, 09:30 PM UTC
M
HeartSciences posts $3.2M FQ1 2027 net loss; no meaningful revenue
HeartSciences reported a $3.2 million net loss for its fiscal first quarter ended July 31, 2026, with no meaningful revenue. Loss from operations was $2.9 million, including a $0.3 million inventory reserve tied to its w
EARNINGS | Sep 15, 2026, 09:15 PM UTC
H
HeartSciences Inc. (NASDAQ:HSCS) Posts Wider FQ1 Loss; Fortitude Deal on Track
HeartSciences reported FQ1 2027 net loss of $3.2M vs $2.1M and no meaningful revenue. The Fortitude merger is expected to close in Q4 2026, subject to conditions.Material DetailsContext by AI AnalystThis is early-stage c
EARNINGS | Sep 15, 2026, 01:31 PM UTC
L
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026Commercial effort concentrated on the
EARNINGS | Sep 15, 2026, 01:31 PM UTC
L
HeartSciences Had a Shareholders' Deficit of $2M at July 31 >HSCS
HeartSciences Had a Shareholders' Deficit of $2M at July 31 >HSCS
NEWS | Sep 15, 2026, 01:28 PM UTC
L
HeartSciences 1Q Loss $3.2M >HSCS
HeartSciences 1Q Loss $3.2M >HSCS
NEWS | Sep 15, 2026, 01:28 PM UTC
L
HeartSciences Inc. Q1 2027: Revenue $2.1K, Net loss $(3.17M), EPS $(0.86) — 10-Q Summary
HeartSciences Inc. reported results for the quarter ended July 31, 2026 (Q1 2027 fiscal), posting revenue of $2.1K and a net loss of $(3.17M), or diluted EPS of $(0.86). Revenue was essentially flat year—over—year versus
EARNINGS | Sep 14, 2026, 08:22 PM UTC
H
HSCS: Net loss widened to $3.2M as revenue stalled and merger completion remains uncertain
Revenue remained minimal at $2,000 for the quarter ended July 31, 2026, with a net loss of $3.2 million and a working capital deficit of $4.8 million. Focus shifted to MyoVista Insights™, while a merger with Fortitude Mi
EARNINGS | Sep 14, 2026, 08:18 PM UTC
L
HSCS Q1’26 EPS estimate (0.72) USD ahead of Sept. 10 results
HeartSciences Inc. (HSCS) is set to announce Q1’26 results on September 10, with earnings expected at 8:00 AM ET (12:00 PM UTC). Q1’26 revenue estimate is 0 USD; EPS estimate is (0.72) USD.
EARNINGS | Sep 09, 2026, 11:00 AM UTC
L
HeartSciences set to report Q1’26 results Sept. 10
HSCS (HeartSciences Inc.) is set to announce Q1’26 results on September 10, with expected disclosure at 8:00 AM ET. Q1’26 revenue estimate is 0 USD and EPS is anticipated at (0.72) USD.
EARNINGS | Sep 03, 2026, 11:00 AM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Tuesday's intraday session, with Aditxt and Atlantic International leading the gainers and Trinity Biotech and Tenon Medical leading the losers
EQUITY | Jun 23, 2026, 05:09 PM UTC